Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China flag China · Delayed Price · Currency is CNY
63.45
+0.38 (0.60%)
At close: Nov 17, 2026

Shanghai OPM Biosciences Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
821.65354.44296.78242.69294.27212.68
Other Revenue
0.480.480.470.430.1-
822.13354.91297.24243.12294.37212.68
Revenue Growth
132.96%19.40%22.26%-17.41%38.41%70.19%
Cost of Revenue
439.72182.2142.34101.53107.2586
Gross Profit
382.41172.72154.9141.59187.12126.69
Selling, General & Admin
189.9996.12105.9474.476050.96
Research & Development
69.4347.4133.3741.9132.1919.03
Other Operating Expenses
-5.534.082.21-0.231.170.78
Operating Expenses
268.26150.27148.44122.5798.1171.09
Operating Income
114.1522.456.4619.028955.6
Interest Expense
-5.88-2.69-3.12-3.23-4.98-4.79
Interest & Investment Income
39.2443.6531.1436.317.989.07
Currency Exchange Gain (Loss)
-5.09-5.092.40.872.24-0.24
Other Non Operating Income (Expenses)
-16.54-0.06-0.05-0.09-0.14-0.07
EBT Excluding Unusual Items
125.8858.2536.8452.89104.0959.57
Gain (Loss) on Sale of Investments
-75.51-4.894.631.531.67-
Gain (Loss) on Sale of Assets
-0.48-0.030.09-0.020.29-0.02
Asset Writedown
-11.81-9.55-7.51---
Other Unusual Items
5.595.592.387.2613.388.61
Pretax Income
43.6749.3736.4361.67119.4368.15
Income Tax Expense
7.428.3616.198.4114.067.76
Earnings From Continuing Operations
36.2441.0220.2453.26105.3760.39
Minority Interest in Earnings
4.90.680.820.78--
Net Income
41.1441.721.0554.04105.3760.39
Net Income to Common
41.1441.721.0554.04105.3760.39
Net Income Growth
-4.87%98.07%-61.04%-48.72%74.47%416.87%
Shares Outstanding (Basic)
13311311111510186
Shares Outstanding (Diluted)
13311311711510186
Shares Change
12.80%-3.64%1.72%13.48%17.43%0.20%
EPS (Basic)
0.310.370.190.471.040.70
EPS (Diluted)
0.310.370.180.471.040.70
EPS Growth
-15.66%105.56%-61.70%-54.81%48.57%415.84%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
169.2247.32-51.61-19.59-35.348.64
Free Cash Flow Per Share
1.270.42-0.44-0.17-0.350.10
Dividend Per Share
0.6300.4300.4200.4400.429-
Dividend Growth
215.00%2.30%-4.47%2.66%--
Gross Margin
46.51%48.67%52.11%58.24%63.57%59.56%
Operating Margin
13.88%6.33%2.17%7.82%30.23%26.14%
Profit Margin
5.00%11.75%7.08%22.23%35.80%28.40%
Free Cash Flow Margin
20.58%13.33%-17.36%-8.06%-12.01%4.06%
EBITDA
157.662.7542.5647.04113.2874.34
EBITDA Margin
19.17%17.68%14.32%19.35%38.48%34.96%
D&A For EBITDA
43.4540.336.128.0224.2818.74
EBIT
114.1522.456.4619.028955.6
EBIT Margin
13.88%6.33%2.17%7.82%30.23%26.14%
Effective Tax Rate
17.00%16.92%44.45%13.63%11.78%11.39%
Revenue as Reported
822.13354.91297.24243.12294.37212.68
Advertising Expenses
-3.112.082.291.340.73